» Articles » PMID: 22863902

Isolation of Aspergillus Species from the Airway of Lung Transplant Recipients is Associated with Excess Mortality

Overview
Journal J Infect
Date 2012 Aug 7
PMID 22863902
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Aspergillus spp. are the leading cause of invasive fungal infection in lung transplant recipients. We investigated the relationship between the isolation of Aspergillus spp. from the respiratory tract of lung transplant recipients and their risk of mortality.

Methods: A retrospective, observational cohort study of all patients who received lung allografts between January 1999 and May 2011 at a single UK centre was performed. The time from transplantation to death was analysed using Cox regression models. Isolation of Aspergillus spp. from the respiratory tract was included as a covariate in the Cox regression model.

Results: Two hundred-thirteen patients were included. The median follow-up time was 5 years during which 102 patients (47.9%) died. Aspergillus was isolated from 74 (34.7%) patients. Twenty patients (27%) had Aspergillus isolated in the first 60 days post-transplant. Forty-one patients (55.4%) in the Aspergillus group and 61 patients (43.9%) in the non-Aspergillus group died during follow-up. A hazard ratio of 2.2 (95% CI 1.5-3.3; P < 0.001) for death following a positive Aspergillus sample was observed.

Conclusion: Isolation of Aspergillus spp. from patients following lung transplantation is associated with a significant increase in mortality. Novel preventative strategies are required to minimise the impact of Aspergillus in lung transplant recipients.

Citing Articles

Machine learning model predicts airway stenosis requiring clinical intervention in patients after lung transplantation: a retrospective case-controlled study.

Tian D, Zuo Y, Yan H, Huang H, Liu M, Yang H BMC Med Inform Decis Mak. 2024; 24(1):229.

PMID: 39160522 PMC: 11331769. DOI: 10.1186/s12911-024-02635-8.


Fungal Tracheobronchitis in Lung Transplant Recipients: Incidence and Utility of Diagnostic Markers.

Hammarstrom H, Magnusson J, Stjarne Aspelund A, Stenmark J, Isaksson J, Kondori N J Fungi (Basel). 2023; 9(1).

PMID: 36675824 PMC: 9861951. DOI: 10.3390/jof9010003.


Real-World Financial and Clinical Impact of Diagnostic-Driven and Empirical-Treatment Strategies in High-Risk Immunocompromised Patients with Suspected Aspergillus Infection in the United Kingdom.

Earnshaw S, McDade C, Bryan A, Ines M, Micallef C, Sung A Microbiol Spectr. 2022; 10(3):e0042522.

PMID: 35532266 PMC: 9241825. DOI: 10.1128/spectrum.00425-22.


Multivariate Analysis As a Support for Diagnostic Flowcharts in Allergic Bronchopulmonary Aspergillosis: A Proof-of-Concept Study.

Vitte J, Ranque S, Carsin A, Gomez C, Romain T, Cassagne C Front Immunol. 2017; 8:1019.

PMID: 28878778 PMC: 5572279. DOI: 10.3389/fimmu.2017.01019.


Voriconazole Exposure and Risk of Cutaneous Squamous Cell Carcinoma, Aspergillus Colonization, Invasive Aspergillosis and Death in Lung Transplant Recipients.

Mansh M, Binstock M, Williams K, Hafeez F, Kim J, Glidden D Am J Transplant. 2015; 16(1):262-70.

PMID: 26372838 PMC: 4718897. DOI: 10.1111/ajt.13431.